 |
Corporate News
14-Feb-24
|
|
|
|
|
|
|
|
|
|
|
|
Gland Pharma allots 6,200 equity shares under ESOS
|
|
|
|
|
|
|
|
Gland Pharma has allotted 6,200 equity shares under ESOS on 14 February 2024. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 164,708,123 /- comprising of 164,708,123 Equity shares of face value Re.1/- each.
|
|
|
|
Previous News |
Benchmarks trade with significant gains; VIX tumbles 9.39%
(
Market Commentary
-
Mid-Session
07-Aug-24
12:36
)
|
|
|
Volumes jump at Gland Pharma Ltd counter
(
Hot Pursuit
-
23-May-24
11:00
)
|
|
|
Gland Pharma Ltd slips for fifth straight session
(
Hot Pursuit
-
19-Sep-24
13:35
)
|
|
|
Board of Gland Pharma recommends final dividend
(
Corporate News
-
23-May-24
09:38
)
|
|
|
Gland Pharma consolidated net profit declines 34.64% in the June 2022 quarter
(
Results
-
Announcements
20-Jul-22
17:47
)
|
|
|
Gland Pharma Ltd slips for fifth straight session
(
Hot Pursuit
-
20-Feb-23
09:32
)
|
|
|
Gland Pharma receives USFDA approval for Eribulin Mesylate Injection
(
Corporate News
-
06-Apr-24
17:40
)
|
|
|
Gland Pharma Ltd soars 4.97%, rises for fifth straight session
(
Hot Pursuit
-
09-Aug-23
13:00
)
|
|
|
Gland Pharma Ltd spurts 3.65%, up for five straight sessions
(
Hot Pursuit
-
05-Oct-21
13:00
)
|
|
|
Gland Pharma to conduct board meeting
(
Corporate News
-
05-Jul-22
10:28
)
|
|
|
Gland Pharma Q1 PAT drops 35% YoY to Rs 229 cr
(
Hot Pursuit
-
20-Jul-22
17:47
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|